Should You Buy DENTSPLY SIRONA Inc (XRAY) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
DENTSPLY SIRONA Inc (XRAY) is not a strong buy for a beginner, long-term investor at this moment. The stock lacks positive momentum, has weak financial performance, and no significant catalysts to drive growth in the near term. Holding off on investment until clearer signs of recovery or growth emerge is recommended.
Technical Analysis
The MACD is slightly positive but contracting, RSI is neutral at 59.289, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point (12.494) with resistance at 12.905 and support at 12.083.
Analyst Ratings and Price Target Trends
Analyst sentiment is mixed to negative, with most firms maintaining Neutral or Underweight ratings. Price targets range from $12 to $14, reflecting limited upside potential in the near term.
Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is 13.04 USD with a low forecast of 12 USD and a high forecast of 17 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is 13.04 USD with a low forecast of 12 USD and a high forecast of 17 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 12.310
Current: 12.310
